Saniona Logo

Saniona

Biopharmaceutical company developing ion channel modulators for neurological disorders.

SANION | ST

Overview

Corporate Details

ISIN(s):
SE0005794617 (+1 more)
LEI:
549300XO4L9XNOCFCZ84
Country:
Denmark
Address:
Smedeland 26 B, 2600 GLOSTRUP

Description

Saniona is a clinical-stage biopharmaceutical company focused on the research and development of treatments for neurological disorders, with a primary emphasis on epilepsy. The company is a leader in the field of ion channel modulation, leveraging its expertise and a proprietary drug discovery engine to create new medicines. Saniona has developed an extensive library of over 20,000 proprietary molecules designed to target various ion channels. Its pipeline includes multiple potential new medicines advancing through clinical trials, with the goal of addressing unmet medical needs for patients with central nervous system diseases.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 08:00 Swedish 1000.5 KB
2025-11-27 08:00 English 887.7 KB
2025-09-04 08:00
Saniona väljer SAN2668 som först-i-klassen klinisk kandidat för pediatrisk epil…
Swedish 220.1 KB
2025-09-04 08:00
Saniona selects SAN2668 as first-in-class clinical candidate for paediatric epi…
English 218.7 KB
2025-08-28 08:00 Swedish 1.2 MB
2025-08-28 08:00 English 1.1 MB
2025-08-20 13:30
Saniona ingår exklusivt licensavtal med Jazz Pharmaceuticals för att utveckla o…
Swedish 232.7 KB
2025-08-20 13:30
Saniona Enters Exclusive Licensing Agreement with Jazz Pharmaceuticals to Devel…
English 233.7 KB
2025-07-31 08:00
Ändring av antalet aktier och röster i Saniona AB
Swedish 151.7 KB
2025-07-31 08:00
Change in number of shares and votes in Saniona AB
English 150.7 KB
2025-06-26 17:30
Fenja Capital II A/S requests conversion of the remaining outstanding convertib…
English 146.1 KB
2025-06-26 17:30
Fenja Capital II A/S påkallar konvertering av resterande utestående konvertible…
Swedish 146.6 KB
2025-05-28 17:05
Kommuniké från årsstämma den 28 maj 2025 i Saniona AB
Swedish 216.1 KB
2025-05-28 17:05
Bulletin from the Saniona AB annual shareholders’ meeting on May 28, 2025
English 216.0 KB
2025-05-28 08:00 Swedish 1.2 MB

Automate Your Workflow. Get a real-time feed of all Saniona filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Saniona

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Saniona via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-01 Thomas Feldthus Other Other 220,000 1,073,600.00 SEK
2025-04-01 Pierandrea Muglia Other Other 53,333 260,265.04 SEK
2025-04-01 Thomas Feldthus Other Other 30,000 146,400.00 SEK
2024-10-02 John Haurum Other Buy 67,100 60,363.16 SEK
2024-10-02 John Haurum Other Buy 12,361 51,415.58 SEK
2024-01-29 Pierandrea Muglia Other Other 53,333 219,731.96 SEK
2022-07-05 Karl Johan Bertil Sundberg Other Buy 40,000 142,128.00 SEK
2022-07-05 Thomas Feldthus Other Buy 30,000 130,590.00 SEK
2022-07-05 Thomas Feldthus Other Buy 30,000 129,600.00 SEK
2022-07-05 Thomas Feldthus Other Buy 5,221 22,685.24 SEK

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.